成人COVID-19患者困难气道管理:气道管理学会声明
气道管理学会(SAM)成立工作组,复习现有文献与美国麻醉医师学会困难气道管理指南,制定成人COVID-19已知或疑似困难气道管理推荐,目标是在优化插管成功同时最小化医护人员暴露风险,推荐经共识 unanimous 批准。
要点
- COVID-19患者气道管理增加医护人员暴露风险,必须严格遵循个人防护装备方案。
- 若评估适合清醒气管插管,应避免可能增加气溶胶的操作;诱导前用紧密面罩最佳预氧合。
- 视频喉镜推荐为一线策略;紧急有创气道通路推荐手术技术如刀-探条-管,而非经气管喷射通气。
核心结论
- SAM工作组针对成人COVID-19已知或疑似困难气道提出推荐,以优化气道管理成功率并最小化医护人员暴露风险。
研究设计与样本
- SAM成立工作组,复习现有文献及美国麻醉医师学会困难气道管理指南,各成员按标准搜索引擎检索特定临床章节,推荐经工作组讨论并全体一致批准,采用AGREE报告清单要素制定声明。
主要发现
- COVID-19患者气道管理增加医护人员暴露风险,困难气道管理常耗时更长且可能涉及多种产生气溶胶的操作。
- 当气道风险评估提示适合清醒气管插管时,应避免可能增加分泌物气溶胶化的操作。
- 诱导前用紧密密封面罩进行最佳预氧合可降低低氧血症风险;除非患者出现氧饱和度下降,诱导后可不进行正压面罩通气以减少气溶胶化。
- 为获得最佳插管条件,患者应接受充分麻醉与完整肌肉松弛;视频喉镜推荐为气道管理一线策略。
- 若有紧急有创气道通路指征,推荐手术技术如刀-探条-管,而非经气管喷射通气等产生气溶胶的操作。
临床怎么用
- 对已知或疑似COVID-19成人困难气道,严格遵循PPE方案,优先选择视频喉镜,并依据氧饱和度决定是否正压面罩通气。
- 清醒气管插管适合时避免增加气溶胶的操作,紧急有创气道选择手术技术而非经气管喷射通气。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The coronavirus disease 2019 (COVID-19) disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), often results in severe hypoxemia requiring airway management. Because SARS-CoV-2 virus is spread via respiratory droplets, bag-mask ventilation, intubation, and extubation may place health care workers (HCW) at risk. While existing recommendations address airway management in patients with COVID-19, no guidance exists specifically for difficult airway management. Some strategies normally recommended for difficult airway management may not be ideal in the setting of COVID-19 infection. To address this issue, the Society for Airway Management (SAM) created a task force to review existing literature and current practice guidelines for difficult airway management by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. The SAM task force created recommendations for the management of known or suspected difficult airway in the setting of known or suspected COVID-19 infection. The goal of the task force was to optimize successful airway management while minimizing exposure risk. Each member conducted a literature review on specific clinical practice section utilizing standard search engines (PubMed, Ovid, Google Scholar). Existing recommendations and evidence for difficult airway management in the COVID-19 context were developed. Each specific recommendation was discussed among task force members and modified until unanimously approved by all task force members. Elements of Appraisal of Guidelines Research and Evaluation (AGREE) Reporting Checklist for dissemination of clinical practice guidelines were utilized to develop this statement. Airway management in the COVID-19 patient increases HCW exposure risk. Difficult airway management often takes longer and may involve multiple procedures with aerosolization potential, and strict adherence to personal protective equipment (PPE) protocols is mandatory to reduce risk to providers. When a patient's airway risk assessment suggests that awake tracheal intubation is an appropriate choice of technique, and procedures that may cause increased aerosolization of secretions should be avoided. Optimal preoxygenation before induction with a tight seal facemask may be performed to reduce the risk of hypoxemia. Unless the patient is experiencing oxygen desaturation, positive pressure bag-mask ventilation after induction may be avoided to reduce aerosolization. For optimal intubating conditions, patients should be anesthetized with full muscle relaxation. Videolaryngoscopy is recommended as a first-line strategy for airway management. If emergent invasive airway access is indicated, then we recommend a surgical technique such as scalpel-bougie-tube, rather than an aerosolizing generating procedure, such as transtracheal jet ventilation. This statement represents recommendations by the SAM task force for the difficult airway management of adults with COVID-19 with the goal to optimize successful airway management while minimizing the risk of clinician exposure.
引用
- Foley LJ, Urdaneta F, Berkow L, et al. Difficult Airway Management in Adult Coronavirus Disease 2019 Patients: Statement by the Society of Airway Management. Anesth Analg. 2021. PMID: 33711004. doi:10.1213/ANE.0000000000005554
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。